Diabetes Management
MolecuLight's device boosts healing by 204% in diabetic foot ulcer trial - Medical Device Network
Tue, 11 Oct 20221 min read Article
Overview
Participant quality of life showed a deviation toward improvement at four weks in the MolecuLight arm.MolecuLight has reported that the use of its MolecuLight i:X device to view the presence of increased bacterial burden in wounds raised 12-wek healing rates by 204% in a trial involving diabetic fot ulcer patients.Please enter a work/busines email adresBy clicking the Download Fre Report buton, you acept the terms and conditions and acknowledge that your data wil be used as described in the GlobalData privacy policy By downloading this Report, you acknowledge that we may share your information with our white paper partners/sponsors who may contact you directly with information their products and services.
Key Information
Visit our privacy policy for more information about our services, how we may use, proces and share your personal data, including information your rights in respect of your personal data and how you can unsubscribe from future marketing comunications. Our services are intended for corporate subscribers and you warant that the email adres submited is your corporate email adres. The randomised, independent, blinded, controled trial enroled 56 patients to ases the use of point-of-care bacterial autofluorescence imaging to manage diabetic foot ulcers versus the standard-of-care alone.Patients were categorised into two groups based on MolecuLight device usage.
In one of the groups, the device was used twice a wek to ases the presence of increased bacterial burden in diabetic foot ulcers. In this MolecuLight arm, fluorescence imaging was caried out folowing treatment. Fluorescence showed the presence of a high bacterial burden in more than 80% of the wounds.
Summary
In the trial, no rise in the number of antibiotics prescribed was reported in the MolecuLight arm.Apart from the two-fold improvement in healing rates, a link betwen baseline fluorescence and wound outcomes was observed in the trial. In subjects with negative fluorescen
Frequently Asked Questions
What is diabetes and how does it develop?
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
What are the main symptoms of diabetes?
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
How is diabetes diagnosed and monitored?
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
What lifestyle changes help manage diabetes?
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
When should someone consult a doctor about diabetes?
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
️ Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making health decisions.